Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Greater than 200 billion annually--

RE: Greater than 200 billion annually--

posted on Oct 25, 2005 03:20PM
``Global sales of end products deploying chips using technologies protected by the jointly owned patents are estimated to be greater than $200 billion annually``

I think they could have been a little more accurate and given us the annual value of infringing chips rather than the value of the products including these chips. As we have seen OEM`s are not the target of the infringement, the chip manufacturers are.

Anyhow a bright spot is that TPL used us in a PR!

Share
New Message
Please login to post a reply